AU2003255621A8 - Topical use of at least one double-stranded rna oligonucleotide (ds rna) - Google Patents
Topical use of at least one double-stranded rna oligonucleotide (ds rna)Info
- Publication number
- AU2003255621A8 AU2003255621A8 AU2003255621A AU2003255621A AU2003255621A8 AU 2003255621 A8 AU2003255621 A8 AU 2003255621A8 AU 2003255621 A AU2003255621 A AU 2003255621A AU 2003255621 A AU2003255621 A AU 2003255621A AU 2003255621 A8 AU2003255621 A8 AU 2003255621A8
- Authority
- AU
- Australia
- Prior art keywords
- double
- rna
- stranded rna
- topical use
- rna oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
The invention relates to a novel use of at least one double-stranded RNA oligonucleotide (ds RNA) for a topical application and topical compositions comprising at least one double-stranded RNA oligonucleotide encapsulated within a physiologically-acceptable medium. The invention further relates to a cosmetic treatment method using at least one double-stranded RNA oligonucleotide.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0206796A FR2840217B1 (en) | 2002-06-03 | 2002-06-03 | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA OLIGONUCLEOTIDE (DSRNA) AND USES THEREOF |
FR02/06796 | 2002-06-03 | ||
US38672002P | 2002-06-10 | 2002-06-10 | |
US60/386,720 | 2002-06-10 | ||
PCT/FR2003/001648 WO2003101376A2 (en) | 2002-06-03 | 2003-06-02 | Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003255621A1 AU2003255621A1 (en) | 2003-12-19 |
AU2003255621A8 true AU2003255621A8 (en) | 2003-12-19 |
Family
ID=29713354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003255621A Abandoned AU2003255621A1 (en) | 2002-06-03 | 2003-06-02 | Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1513482B1 (en) |
JP (1) | JP4499554B2 (en) |
AT (1) | ATE464038T1 (en) |
AU (1) | AU2003255621A1 (en) |
CA (1) | CA2485111A1 (en) |
DE (1) | DE60332112D1 (en) |
ES (1) | ES2342826T3 (en) |
WO (1) | WO2003101376A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10254214A1 (en) * | 2002-11-20 | 2004-06-09 | Beiersdorf Ag | Oligoribonucleotides for the treatment of degenerative skin symptoms by RNA interference |
GB0307914D0 (en) * | 2003-04-07 | 2003-05-14 | Univ Dundee | Cytochrome p450 |
CA2543135A1 (en) * | 2003-10-21 | 2005-05-12 | Dyad Pharmaceutical Corporation | Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions |
DE102004025881A1 (en) | 2004-05-19 | 2006-01-05 | Beiersdorf Ag | Oligoribonucleotides for influencing hair growth |
WO2006040446A1 (en) * | 2004-10-07 | 2006-04-20 | L'oreal | Method for shaping keratin fibres |
WO2006040447A1 (en) * | 2004-10-07 | 2006-04-20 | L'oreal | Method for cosmetic treatment of keratin fibres and use of a transglutaminase modulator |
US9139850B2 (en) | 2005-05-19 | 2015-09-22 | L'oreal | Vectorization of dsRNA by cationic particles and topical use |
FR2885813B1 (en) * | 2005-05-19 | 2008-01-11 | Oreal | VECTORIZATION OF DSRNA BY CATIONIC PARTICLES AND THEIR USE ON SKIN MODEL. |
FR2885808B1 (en) | 2005-05-19 | 2007-07-06 | Oreal | VECTORIZATION OF DSRNA BY CATIONIC PARTICLES AND TOPICAL USE. |
FR2890859B1 (en) * | 2005-09-21 | 2012-12-21 | Oreal | DOUBLE-STRANDED RNA OLIGONUCLEOTIDE INHIBITING TYROSINASE EXPRESSION |
JP4981381B2 (en) * | 2006-08-04 | 2012-07-18 | 株式会社ナリス化粧品 | Skin external preparation for whitening |
JP2008115101A (en) * | 2006-11-02 | 2008-05-22 | Naris Cosmetics Co Ltd | Skin-bleaching composition |
TWI382849B (en) * | 2007-10-29 | 2013-01-21 | Mello Biotech Taiwan Co Ltd | Method of producing cosmetic product for skin care in ways of gene silencing effect and genetic recombinant nucleic acids encoding gene silencing effector |
FR2940977B1 (en) * | 2009-01-13 | 2016-11-18 | Oreal | USE OF COMPLEX FORMS OF THE CALMODULIN-LIKE SKIN PROTEIN CLSP PROTEIN |
FR2986233B1 (en) | 2012-02-01 | 2014-02-28 | Regentis Internat | BIFUNCTIONAL PEPTIDE |
FR3043695B1 (en) * | 2015-11-17 | 2019-10-25 | ISP Investments LLC. | PROCESS FOR OBTAINING AQUEOUS EXTRACT ENRICHED IN SMALL RNA FROM PLANT MATERIAL AND EXTRACTS FROM THE PROCESS |
FR3106754B1 (en) | 2020-02-04 | 2022-01-07 | Isp Investments Llc | METHOD FOR OBTAINING AN AQUEOUS LAVENDER EXTRACT, COMPOSITIONS COMPRISING SUCH AN EXTRACT AND THEIR COSMETIC USES |
JPWO2021201276A1 (en) * | 2020-04-03 | 2021-10-07 | ||
FR3116438B1 (en) | 2020-11-23 | 2022-10-14 | Isp Investments Llc | METHOD FOR OBTAINING AQUEOUS EXTRACTS FROM TEA LEAVES, COMPOSITIONS COMPRISING SUCH EXTRACTS AND THEIR COSMETIC USES |
FR3125425A1 (en) | 2021-07-22 | 2023-01-27 | Isp Investments Llc | EXTRACT OF BLACK TEA LEAVES, COMPOSITIONS COMPRISING THEM AND COSMETIC USES THEREOF |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9927444D0 (en) * | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
FR2804960B1 (en) * | 2000-02-11 | 2005-06-24 | Lvmh Rech | NOVEL OLIGONUCLEOTIDES AND USE OF OLIGONUCLEOTIDES MODULATING THE EXPRESSION OF TYROSINASE AND TYROSINASE-RELATED-PROTEIN 1 AS DEPIGMENTING AGENTS |
-
2003
- 2003-06-02 JP JP2004508734A patent/JP4499554B2/en not_active Expired - Fee Related
- 2003-06-02 AU AU2003255621A patent/AU2003255621A1/en not_active Abandoned
- 2003-06-02 AT AT03756039T patent/ATE464038T1/en not_active IP Right Cessation
- 2003-06-02 CA CA002485111A patent/CA2485111A1/en not_active Abandoned
- 2003-06-02 WO PCT/FR2003/001648 patent/WO2003101376A2/en active Application Filing
- 2003-06-02 EP EP03756039A patent/EP1513482B1/en not_active Expired - Lifetime
- 2003-06-02 DE DE60332112T patent/DE60332112D1/en not_active Expired - Lifetime
- 2003-06-02 ES ES03756039T patent/ES2342826T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4499554B2 (en) | 2010-07-07 |
ATE464038T1 (en) | 2010-04-15 |
WO2003101376A3 (en) | 2004-05-06 |
ES2342826T3 (en) | 2010-07-15 |
AU2003255621A1 (en) | 2003-12-19 |
EP1513482A2 (en) | 2005-03-16 |
WO2003101376A2 (en) | 2003-12-11 |
CA2485111A1 (en) | 2003-12-11 |
JP2005530812A (en) | 2005-10-13 |
EP1513482B1 (en) | 2010-04-14 |
DE60332112D1 (en) | 2010-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003255621A8 (en) | Topical use of at least one double-stranded rna oligonucleotide (ds rna) | |
AU2003279010A1 (en) | Compositions and methods for delivery of short interfering rna and short hairpin rna | |
AU2001268126A1 (en) | Compositions, kits, and methods for promoting defined health benefits | |
AU7621600A (en) | Human rnase h and oligonucleotide compositions thereof | |
AU2001276048A1 (en) | Rapid-melt semi-solid compositions, methods of making same and methods of using same | |
HK1044545A1 (en) | Human beta-secretase enzyme, inhibitors and their compositions and uses | |
AU2002311903A1 (en) | Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto | |
HK1081957A1 (en) | Benzopyranone compounds, compositions thereof, and methods of treatment therewith | |
EP1927587A3 (en) | Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof | |
ATE508731T1 (en) | HAIR TREATMENT COMPOSITIONS THAT ADD VOLUME TO HAIR AND CONTAIN PRESSURE-SENSITIVE SILICONE ADHESIVES | |
GB0500265D0 (en) | Methods and compositions relating to labeled rna molecules that reduce gene expression | |
EP1667999A4 (en) | Benzopyranone compounds, compositions thereof, and methods of treatment therewith | |
FR2840217B1 (en) | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE DOUBLE-STRANDED RNA OLIGONUCLEOTIDE (DSRNA) AND USES THEREOF | |
IL161039A0 (en) | Mupirocin compositions for topical use, and improved process of making same and methods of using same | |
SG118236A1 (en) | Compositions and methods for treating coronavirus infection and SARS | |
MXPA03007653A (en) | Use of lp82 to treat hematopoietic disorders. | |
MXPA03011128A (en) | Flavour and fragrance compositions. | |
EP1648525A4 (en) | Methods of producing, marketing and using odor control compositions | |
TW200512009A (en) | Hair treatment compositions | |
AU2003221480A1 (en) | Hair treatment compositions | |
ITRM20020115A0 (en) | EXPRESSION OF LYSOSOMIAL ENZYMES IN SEED. | |
WO2003099224A3 (en) | Antisense moodulation of kinesin-like 1 expression | |
EP1546377A4 (en) | Methods and compositions to treat pain and painful disorders using 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 or 13424 molecules | |
AU2003290970A1 (en) | Compositions and method for treating affective, painful or allergic disorders | |
AU2003275433A1 (en) | Compositions and methods for treating pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |